GlassScriptPhysician profile
William Miles Reeves
NPI 1023549698
$5,311.06
in general payments reported to CMS, 2019-2025
31 companies · $1,047 in 2025
The $1,047 reported for 2025 was more than what 92% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $124 · 2021: $351 · 2022: $1,498 · 2023: $1,117 · 2024: $1,065 · 2025: $1,047.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,229.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $1,015.84 | 2023-2025 | Myfembree |
| Abbvie INC. | $915.15 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $403.13 | 2023-2025 | |
| Shield Therapeutics INC | $282.06 | 2022-2025 | Accrufer |
| Exeltis, USA INC. | $230.23 | 2021-2025 | Slynd |
| Optumhealth Care Solutions, LLC | $211.15 | 2023-2025 | Vivify Health Care Team Portal 001, Eitan Medical, Vivify Health Care Team Portal |
| Myovant Sciences INC. | $207.21 | 2021-2022 | |
| Channel Medsystems, INC. | $200.13 | 2022-2025 | |
| Organon LLC | $199.49 | 2021-2025 | Nexplanon |
| Mylan Pharmaceuticals INC. | $181.61 | 2021-2022 | |
| Astellas Pharma US INC | $169.46 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $160.99 | 2021-2025 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Sage Therapeutics, LLC | $137.97 | 2024-2025 | Zurzuvae |
| Evofem Biosciences, INC. | $136.40 | 2021-2023 | Phexxi |
| Astrazeneca Pharmaceuticals LP | $124.21 | 2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $114.05 | 2021-2025 | |
| Agile Therapeutics, INC. | $83.14 | 2022-2023 | Twirla |
| Momentis Surgical INC. | $74.00 | 2022 | |
| Boston Scientific Corporation | $60.78 | 2019 | |
| Scynexis, INC. | $58.47 | 2022 | |
| Dexcom, INC. | $56.68 | 2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $53.61 | 2022-2024 | |
| Exact Sciences Corporation | $44.24 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Coopersurgical, INC. | $35.81 | 2024 | Fisherbrand Disposable Liquid Infant Heel Warmer |
| Aspira Women'S Health INC | $35.23 | 2022 | |
| Therapeuticsmd, INC. | $26.24 | 2021-2022 | |
| Avanos Medical | $24.48 | 2019 | |
| Meditrina | $20.25 | 2022 | |
| Millicent US INC | $17.99 | 2025 | Femlyv, Intrarosa |
| Minerva Surgical, INC | $17.32 | 2025 | |
| Gynesonics, INC. | $13.74 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Reeves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.